Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Boston Scientific Corp (BSX)

Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Boston Scientific Corp 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752 USA

www.bostonscientific.com Employees: 53,000 P: 508-683-4000 F: 508-650-8923

Sector:

Medical

Description:

Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.

Key Statistics

Overview:

Market Capitalization, $K 135,198,704
Enterprise Value, $K 145,530,704
Shares Outstanding, K 1,482,442
Float, K 1,475,030
% Float 99.50%
Short Interest, K 20,011
Short Float 1.35%
Days to Cover 2.37
Short Volume Ratio 0.35
% of Insider Shareholders 0.50%
% of Institutional Shareholders 89.07%

Financials:

Annual Sales, $ 16,747 M
Annual Net Income, $ 1,854 M
Last Quarter Sales, $ 5,065 M
Last Quarter Net Income, $ 755,000 K
EBIT, $ 4,360 M
EBITDA, $ 6,015 M

Growth:

1-Year Return -8.96%
3-Year Return 98.65%
5-Year Return 157.34%
5-Year Revenue Growth 56.00%
5-Year Earnings Growth 58.86%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.75 on 10/22/25
Next Earnings Date 02/04/26 [BMO]
Earnings Per Share ttm 2.95
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 19.05%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 11/06/03

BSX Ratios

Ratio
Price/Earnings ttm 29.85
Price/Earnings forward 25.50
Price/Earnings to Growth 1.56
Return-on-Equity % 19.46%
Return-on-Assets % 10.78%
Profit Margin % 11.07%
Debt/Equity 0.49
Price/Sales 7.04
Price/Cash Flow 24.13
Price/Book 5.53
Book Value/Share 15.94
Interest Coverage 8.48
60-Month Beta 0.67
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar